CANCER TREATMENT BREAKTHROUGHS
How Russian cancer vaccines EnteroMix and personalized mRNA work to control the life-threatening disease
Russia's cancer vaccine, comprising EnteroMix and personalized mRNA vaccines, has completed preclinical trials, showcasing safety and high efficacy. Research conducted by the NMRRC demonstrated tumor size reduction and slowed progression, ranging from 60% to 80%, alongside increased survival rates. The vaccines aim to destroy malignant cells and activate the patient's antitumor immunity.
A 100% effective cancer vaccine? Russia’s Enteromix achieves success in trials; Here’s the full report you need to read
Russia's Enteromix vaccine has demonstrated 100% efficacy in preclinical trials, showing promise in fighting tumors. The vaccine, initially targeting colorectal cancer, has shown significant tumor reduction and improved survival rates. Researchers are also developing versions for glioblastoma and melanoma, potentially revolutionizing cancer treatment.
Sheinelle Jones' husband died of glioblastoma: Why is this brain cancer so deadly and aggressive? Check signs to spot it
Sheinelle Jones has opened up after the death of her husband, Uche Ojeh who died of glioblastoma, an aggressive form of brain cancer. Glioblastoma multiforme (GBM) is the most malignant and pervasive subtype of glioma and is the most common primary brain tumor in adults. GBM is considered deadly due to its rapid growth and aggressive nature.
America’s biggest health problem is silently killing millions — chronic diseases are skyrocketing. Are you taking the right steps before it strikes?
Nearly 6 in 10 Americans live with at least one chronic disease, with heart disease and diabetes leading the toll. In 2023, over 697,000 deaths were attributed to heart disease, and 115.9 million adults had prediabetes. Chronic conditions now account for 90% of U.S. healthcare spending. Learn how to protect yourself before it's too late.
Godfather of AI envisions superintelligence with a mother’s instinct for a safe future: Powerful, smarter but unfailingly caring
Geoffrey Hinton suggests a novel approach to AI safety. He proposes instilling 'maternal instincts' in AI. This would ensure AI protects humanity. Hinton believes dominance tactics will fail. He envisions AI as a caring mother. This model, he argues, is crucial for a positive future. Other AI leaders suggest different approaches. They focus on human-centered design and collaboration.
- Go To Page 1
How a one-minute jolt from the SetPoint implant offers new hope for autoimmune disease patients
The US Food and Drug Administration has approved a new medical device for rheumatoid arthritis. The SetPoint System is an implant that stimulates the vagus nerve. It reduces inflammation by re-educating the immune system. Clinical trials show promising results with reduced joint pain and swelling. Experts express cautious optimism about this drug-free approach.
Gems & jewellery, textiles to carpets: How Trump’s tariffs are wrecking Indian MSMEs
Major labour-intensive sectors of the Indian economy, such as gems and jewellery, textiles, carpets and handloom are feeling the pinch of unexpected and significant tariff changes imposed by US President Donald Trump.
IIT Madras graduate was told she had Stage 3 lung cancer. She battled brutal chemo, rebuilt her life and made it to Oxford
Rasika Bombatkar, diagnosed with Stage 3 lung cancer at 26, faced a grueling battle involving chemotherapy and surgery. Supported by loved ones, she persevered through immense physical and emotional challenges. Defying the odds, Rasika not only survived but also pursued her dreams, earning a degree from Oxford and now working at the World Health Organization.
Promising HIV cure could be achieved through children: Decade long tests reveal
Global HIV research indicates a potential cure for children through early antiretroviral therapy (ART). A small group of HIV-infected infants achieved viral suppression and remission without ongoing medication, defying typical viral rebound. These children's unique immune systems independently control HIV, offering a blueprint for universal HIV eradication strategies and transforming pediatric HIV care.
Cure for Type 1 diabetes? Cancer research accidentally stumbles upon 90 per cent effective ‘sugar-coating’ method
Mayo Clinic scientists have made a breakthrough in type 1 diabetes treatment. They discovered a 'sugar coating' method. This protects insulin-producing cells from immune attacks. The technique uses sialic acid, inspired by cancer research. Preclinical tests show 90% per cent effectiveness. This could lead to transplants without full immune suppression. Dr. Shapiro hopes for better, long-term solutions for patients.
Homegrown cell, gene therapy pioneer ImmunoACT turns profitable in first year of ops
ImmunoAct, an Indian cell and gene therapy company, has achieved profitability in its first full year, generating ₹62 crore in revenue and ₹12 crore in profit before tax in FY25. Its NexCAR19, an affordable CAR-T therapy, has been administered to over 350 patients across India.
AI is being used to design custom proteins that help immune cells find and kill cancer
Scientists have harnessed artificial intelligence to engineer custom proteins, acting as a GPS for the immune system. These proteins guide T cells with precision to cancer cells, enhancing their ability to destroy tumors effectively. This innovative approach, demonstrated in lab tests, showcases the potential of AI in revolutionizing cancer immunotherapy by creating targeted treatments.
Axiom-4 astronauts saw over 230 sunrises from space, travelled nearly 100 lakh km
Astronaut Shubhanshu Shukla and his Axiom-4 crew, after two weeks on the ISS, have orbited Earth 230 times, covering nearly 100 lakh kms. The crew, including Peggy Whitson, Slawosz Uznanski-Wisniewski, and Tibor Kapu, completed over 60 experiments in various fields, potentially leading to breakthroughs in medicine and space exploration.
Biotech breakthrough? INKT stock skyrockets 530% after cell therapy cures testicular cancer
MiNK Therapeutics made headlines after its stock soared over 500% when one patient with advanced testicular cancer was completely cured using its groundbreaking iNKT cell therapy, agenT-797. This one-time infusion, combined with nivolumab, led to a full, two-year remission with zero side effects. Investors are stunned as this treatment could change the future of cancer care, especially for hard-to-treat solid tumors. The news sent INKT stock skyrocketing, with Wall Street now watching closely. Could this be the future of off-the-shelf cell therapy?
Woman with diabetes says goodbye to insulin after one treatment. But why can’t every diabetic do it?
A revolutionary stem cell therapy has helped Amanda Smith ditch insulin injections for good, offering new hope to diabetics worldwide. The treatment, while effective, still requires lifelong immunosuppressants and faces regulatory hurdles. Researchers call it a major leap forward in diabetes care, but widespread use remains distant.
From Pharaoh’s curse to cancer cure: Deadly Tutankhamun’s tomb fungus may turn out to be a blessing in disguise
Researchers have discovered that Aspergillus flavus, a toxic fungus previously associated with the "curse of the pharaohs," produces compounds with potent anti-cancer activity. These compounds, named asperigimycins, effectively kill leukemia cells by disrupting cell division. This finding highlights the potential of fungi as a source of novel medicines, echoing the discovery of penicillin.
Scientists have found a breakthrough in cancer treatment, and it is deep within the ocean
Scientists at the University of Mississippi have made a significant discovery. They found a rare sugar in sea cucumbers. This sugar shows potential in stopping cancer spread. The compound blocks an enzyme cancer cells use to grow. Unlike other inhibitors, it does not affect blood clotting. Researchers are working to synthesize the compound for further testing.
Are you more likely to be diagnosed with cancer if you are plus-sized? Answer is not so simple, reveals new study
New research reveals that larger animals like elephants and giraffes have higher cancer rates compared to smaller species. However, these species have developed effective cancer-fighting mechanisms. Insights gained from these natural defences could inform innovative approaches for human cancer treatments.
Baba Vanga's 2024 predictions that came true: Economic crisis, climate change, and medical breakthroughs
Baba Vanga, the blind mystic from Bulgaria, left behind unsettling prophecies that continue to captivate the world. Many of her predictions for 2024, including economic turmoil, severe climate changes, and medical breakthroughs, are beginning to unfold. Among the notable developments are advancements in cancer treatment and record-breaking global temperatures. However, more troubling predictions, including bioweapons tests and genetic manipulation, still hang over the future. This article explores the accuracy of her 2024 forecasts and their implications.
New cancer vaccine that trains body's immune system to destroy cancer cells shows promising results
Cancer Vaccine: A new mRNA cancer vaccine developed by Moderna has shown promising early results in clinical trials. The vaccine, mRNA-4359, aims to activate the immune system to target and destroy cancer cells. In a phase-one trial with 19 patients, eight showed no tumour growth. The study is ongoing with melanoma and lung cancer patients.
Tata Institute claims only Rs 100 tablet can prevent recurrence of cancer
The Tata Institute in Mumbai has developed a tablet that could prevent cancer from recurring and reduce side effects of treatment by 50%. The tablet, which will cost just ₹100, is awaiting approval from the Food Safety and Standards Authority of India (FSSAI) and could be available in the market by June-July.
Russian President Vladimir Putin claims significant progress made towards Cancer vaccines
Russian President Vladimir Putin announced that Russian scientists are close to developing cancer vaccines, potentially revolutionizing cancer treatment globally. He shared this breakthrough at a Moscow forum on future technologies, expressing hope for their effective use in individual therapy. While Putin did not specify the targeted cancers or mechanisms, various countries and companies, including the UK and BioNTech, are actively working on similar treatments. This development comes amidst Russia's global distribution of the Sputnik V COVID-19 vaccine, with Putin highlighting vaccine safety and efficacy.
Game-changing Cancer-killing molecule unveiled by scientists; targets tumors, spares healthy cells
In a groundbreaking discovery, scientists at the City of Hope, a leading cancer research institute in the US, have developed a game-changing cancer-killing molecule.
Zydus Cadila launches breast cancer treatment drug Ujvira
"In a step that can significantly reduce treatment cost by almost 80 per cent, the drug is being offered at Rs 32,495 for a 100 mg vial. The current MRP of existing Trastuzumab Emtansine drug is Rs 1,59,225 for 100 mg vial. Ujvira will be available in two strengths, 100 mg and 160 mg," the company added.
Bengalurean’s anti-cancer kit a breakthrough: US
The US Food and Drug Administration (FDA)’s Centre for Devices and Radiological Health has designated a medical invention by a Bengaluru-based scientist as a “breakthrough device” in liver, pancreatic and breast cancer treatment.
Novel temperature-regulating nanoparticles might treat cancer
London, Oct 25 (IANS) Scientists have in a breakthrough developed "intelligent" nanoparticles that have the potential to heat up to a level high enough to kill cancerous cells, but then also self-regulate the temperature and cool down before harming the healthy tissues.
Scientists identify gene behind triple-negative breast cancer
The study opens the door for therapies which suppress the gene and for screening that would pick up the risk early.
Load More
